Featured Research

from universities, journals, and other organizations

Monitoring Program Finds Serious, Unreported Adverse Drug Reactions

Date:
May 8, 2005
Source:
Northwestern University
Summary:
A monitoring program developed by a Northwestern University researcher has successfully identified a large number of previously unknown, serious and often-fatal drug reactions associated with 15 commonly used drugs, including Plavix, thalidomide and drug-coated cardiac stents.

CHICAGO --- A monitoring program developed by a Northwestern University researcher has successfully identified a large number of previously unknown, serious and often-fatal drug reactions associated with 15 commonly used drugs, including Plavixฎ, thalidomide and drug-coated cardiac stents.

Related Articles


As described in an article in the May 4 issue of the Journal of the American Medical Association, the Research on Adverse Drug Events and Reports (RADAR) Project compiles information from reports submitted to the U.S. Food and Drug Administration's database and reports by drug companies and independent researchers throughout the world. RADAR is funded entirely by government grants.

RADAR has proved to be a powerful new instrument that supplements existing FDA surveillance systems and has helped save hundreds to thousands of patient lives, said lead author Charles L. Bennett, M.D., who directs the adverse drug reaction surveillance program. Bennett is professor of medicine in the division of hematology/oncology at Northwestern University Feinberg School of Medicine and a researcher at The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, as well as a physician at the Jesse Brown Veterans Affairs Medical Center and associate director of the VA Mid-West Center for Health Services Research and Policy Studies. RADAR reviews have been published in leading medical journals. Summaries of the reviews have appeared in the media, and in "dear doctor" product warnings and labeling changes sent by pharmaceutical companies.

In the period between 1998 and 2004, Bennett and a multidisciplinary group of RADAR investigators identified serious adverse drug reactions with 14 commonly prescribed drugs, and with cardiac stents, that affected almost 1,700 patients, 170 of whom died as a result of the reaction. The drugs and devices are commonly used, with more than 1 million individuals have been prescribed two of the drugs.

Adverse drug reactions were classified as resulting in death, severe organ failure or requiring major therapeutic interventions, such as cardiopulmonary resuscitation, liver transplantation or placing an individual on a respirator. One particularly severe drug reaction with a novel cancer drug was associated with 67 deaths.

Adverse drug and device reactions account for as many as 100,000 deaths annually. In general, more than half of the most serious adverse drug reactions have been discovered seven or more years after a drug has been marketed.

The recent withdrawal of Vioxx has led to calls for new and independent postmarketing surveillance programs such as RADAR.


Story Source:

The above story is based on materials provided by Northwestern University. Note: Materials may be edited for content and length.


Cite This Page:

Northwestern University. "Monitoring Program Finds Serious, Unreported Adverse Drug Reactions." ScienceDaily. ScienceDaily, 8 May 2005. <www.sciencedaily.com/releases/2005/05/050508152616.htm>.
Northwestern University. (2005, May 8). Monitoring Program Finds Serious, Unreported Adverse Drug Reactions. ScienceDaily. Retrieved March 31, 2015 from www.sciencedaily.com/releases/2005/05/050508152616.htm
Northwestern University. "Monitoring Program Finds Serious, Unreported Adverse Drug Reactions." ScienceDaily. www.sciencedaily.com/releases/2005/05/050508152616.htm (accessed March 31, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Tuesday, March 31, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Solitair Device Aims to Takes Guesswork out of Sun Safety

Solitair Device Aims to Takes Guesswork out of Sun Safety

Reuters - Innovations Video Online (Mar. 31, 2015) — The Solitair device aims to take the confusion out of how much sunlight we should expose our skin to. Small enough to be worn as a tie or hair clip, it monitors the user&apos;s sun exposure by taking into account their skin pigment, location and schedule. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Soda, Salt and Sugar: The Next Generation of Taxes

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015) — Denisa Livingston, a health advocate for the Din้ Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline. Video provided by Washington Post
Powered by NewsLook.com
UnitedHealth Buys Catamaran

UnitedHealth Buys Catamaran

Reuters - Business Video Online (Mar. 30, 2015) — The $12.8 billion merger will combine the U.S.&apos; third and fourth largest pharmacy benefit managers. Analysts say smaller PBMs could also merge. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins